APOA5 and coronary artery disorder: More importantly, exposure to genetically-influenced lower TG levels via APOA5 gave an additional reduction in primary CAD risk on top of exposure to genetically-influenced lower TG via LPL and genetically-influenced lower LDL-C levels.